Dr. Shore Provides an Overview of Biomarkers in Prostate Cancer

Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.

During my "watch and wait" time for prostate cancer, I spend this time wisely on things like attending writing webinars.

One expert explains why double autologous stem cell transplantation is a viable alternative to back-to-back transplant in high-risk multiple myeloma.